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Observational studies have shown that females experience higher
lifetime rates of depression1,2 and that this difference emerges in
mid-puberty and persists throughout adulthood.2,3 Findings
from the UK Psychiatric Morbidity Survey indicate no further
divergence in rates of depression between males and females after
adolescence,4 suggesting that adolescence is the key developmental
period for the emergence of gender differences in depression. It
has been suggested that aspects of the pubertal transition may
underlie the observed increase in depression in females during
adolescence.5 Many studies use menarche – the onset of first
menstrual bleeding – as a proxy for onset of puberty in females,
and associations between early menarche and increased levels of
depressive symptoms and depression in adolescence are widely
reported. Cross-sectional studies report higher levels of depressive
symptoms and depression in girls who have experienced menarche
compared with girls who have not yet experienced this
transition.3,6,7 Many longitudinal studies report that girls with early
menarche have higher levels of depressive symptoms and depression
in adolescence compared with those with later-onset menarche.8–15
It is unclear, however, whether the apparent effect of early
menarche on depressive symptoms/depression persists in the
longer term. Findings from the Avon Longitudinal Study of
Parents and Children (ALSPAC) cohort suggest that by late
adolescence (16–18 years), girls with later-onset menarche
experience similar levels of depressive symptoms to those with
early menarche.11 However, limitations of observational studies,
including confounding, reverse causality and bias, make findings
difficult to interpret. Although randomised controlled trials
(RCTs) are lauded as the ‘gold standard’ of epidemiological
research methods, it would not be possible to examine the
relationship between age at menarche and depression within an
RCT design.16 Mendelian randomisation analysis has been
proposed as a way of determining whether the relationship
between an exposure and outcome is causal, by obtaining a
non-confounded assessment of the relationship.17 Mendelian
randomisation exploits Mendel’s first and second laws. At a
population level, genetic variants (alleles) will not be associated
with confounding factors if: (a) the probability that a germ cell
with any particular allele contributes to a viable conception is
independent of the environment (the principle of segregation),
and (b) allele pairs segregate independently of each other (the
principle of independent assortment).18 This process is analogous
to the randomisation of individuals in a clinical trial. Within a
Mendelian randomisation study, a genetic variant that is robustly
associated with the exposure of interest can be used as an
instrumental variable in analyses,16 serving as a genetic proxy
for the exposure (Fig. 1).
Since it can be assumed that confounders of the relationship
between the exposure and outcome are not associated with the
genetic variants, this approach is particularly useful in instances
where traditional epidemiological methods are likely to suffer
from confounding. The underlying assumptions of Mendelian
randomisation are that:16,19 (a) the genotypes are robustly
associated with the non-genetic exposure of interest; (b) there is
no association between the genotypes and the factors that
confound the relationship between the non-genetic exposure
and outcome of interest; (c) the genotypes only affect the outcome
through the exposure of interest. To our knowledge no previous
study has used causal analysis techniques to examine the
relationship between early menarche and depression/depressive
symptoms. The aim of this study is to exploit Mendelian
randomisation analysis to provide a non-confounded assessment
of these associations. We specifically examine: (a) whether early
onset of menarche is causally associated with depressive symptoms
and depression in adolescence; and (b) whether this effect persists
into late adolescence.
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Background
Observational studies report associations between early
menarche and higher levels of depressive symptoms and
depression. However, no studies have investigated whether
this association is causal.
Aims
To determine whether earlier menarche is a causal risk
factor for depressive symptoms and depression in
adolescence.
Method
The associations between a genetic score for age at
menarche and depressive symptoms at 14, 17 and 19 years,
and depression at 18 years, were examined using Mendelian
randomisation analysis techniques.
Results
Using a genetic risk score to indicate earlier timing of
menarche, we found that early menarche is associated
with higher levels of depressive symptoms at 14 years
(odds ratio per risk allele 1.02, 95% CI 1.005–1.04, n=2404).
We did not find an association between the early menarche
risk score and depressive symptoms or depression after
age 14.
Conclusions
Our results provide evidence for a causal effect of age at
menarche on depressive symptoms at age 14.
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Method
Study sample
Analyses were carried out on data from ALSPAC, a population-
based longitudinal study that recruited pregnant women resident
in the Avon area of the UKwith an expected delivery date between
1 April 1991 and 31 December 1992.20,21 The initial cohort
included 14 541 pregnancies and 13 988 children alive at 12
months (n=6762 girls). When the oldest children were 7 years
old, attempts were made to recruit children who were eligible
for, but did not join, the sample at the initial phase.22 In total,
713 new children (n=392 girls) were recruited, resulting in a
starting sample for the current study of 7154 (6762+392) girls.
Only girls with White ethnicity were eligible for this study
(n= 6298); of these, 3920 had at least one outcome measure,
3579 had data on age at menarche, and 3006 had genetic data
(Fig. 2).
The ALSPAC website contains details of all available data
through a fully searchable data dictionary (http://www.bris.ac.
uk/alspac/researchers/data-access/data-dictionary/). The study
and cohort are described extensively elsewhere21,22 with further
details available at: http://www.bristol.ac.uk/alspac/. Ethical
approval for the study was obtained from the ALSPAC Law and
Ethics Committee and the local research ethics committees.
Written informed consent was obtained from all study participants.
Exposure
Age at menarche
Age at menarche was derived from a series of nine postal question-
naires pertaining to pubertal development, sent approximately
yearly from age 8 to 17 years. The questionnaires asked ‘Has your
daughter started her menstrual periods yet?’ and, if yes: ‘How old
was your daughter when she had her first period?’ Answers were
given in years and months. These data were supplemented by
questionnaires administered to girls at two research clinics
attended at 12 years 10 months and 13 years 10 months asking
‘Have you started your periods yet?’ and, if yes: ‘When did you
have your first period?’ The first-reported age at onset was used,
as these results are least likely to be affected by recall bias.
Outcomes
Depressive symptoms
The Short Moods and Feelings Questionnaire (SMFQ) enquires
about the occurrence of depressive symptoms over the past 2
weeks, with response categories ‘True’, ‘Sometimes’, or ‘Not at
all’ for 13 items. The SMFQ has been validated as a tool for
assessing depressive symptoms in adolescence23 and distinguishes
children with depression from those who are not depressed in
general population samples.24 This study uses SMFQ data
collected at mean ages 13 years 10 months, 16 years 8 months,
and 18 years 8 months, hereafter referred to as 14, 17 and 19 years.
At age 14, participants completed the SMFQ at a research
clinic whereas at 17 and 19 years it was included in questionnaires
mailed to participants. We dichotomised the SMFQ scale and
defined high levels of depressive symptoms as a score of 11 or
above. At this cut-off the SMFQ has been found to have high
sensitivity, specificity and negative predictive power, and high
discriminatory ability for an ICD-10 diagnosis of depression at
18 years.23 This cut-off has been used in ALSPAC7,8,25 and
other26,27 studies previously.
Depression
Participants completed a self-administered computerised version
of the Clinical Interview Schedule-Revised (CIS-R) at a research
clinic (mean age 17 years 7 months, hereafter 18 years).28,29 The
CIS-R measures affective and anxiety disorders in the past week
and has been widely used to diagnose depression according to
ICD-10 criteria. It is standardised, has been validated in
adolescents, and is equally reliable whether self-administered or
conducted by a trained interviewer.28,29 The depression diagnosis
examined in this study is ‘any ICD-10 diagnosis of depression’,
referring to any mild, moderate or severe depressive episode.
Genotyping and imputation
The children in ALSPAC were genotyped using the Illumina
HumanHap550 quad chip (Illumina, Inc., San Diego, California,
USA) by the Wellcome Trust Sanger Institute, Cambridge, UK
and the Laboratory Corporation of America, Burlington, USA.
The resulting raw genome-wide data were subjected to standard
quality control methods. Individuals were excluded on the basis of
gender mismatches; minimal (50.325) or excessive heterozygosity
(40.345); disproportionate levels of individual missingness
(43%); cryptic relatedness measured as proportion of identity
by descent (IBD40.1) and insufficient sample replication
(IBD50.8).
The remaining individuals were assessed for evidence of
population stratification by multidimensional scaling analysis
and compared with Hapmap II (release 22) European descent
(CEU), Han Chinese (CHB), Japanese (JPT) and Yoruba (YRI)
reference populations; all individuals with non-European ancestry
were removed. Single nucleotide polymorphisms (SNPs) with a
minor allele frequency of 51%, a call rate of 595% or evidence
for violations of Hardy–Weinberg equilibrium (P5561077)
were removed. Genotypic data were subsequently imputed using
Markov Chain Haplotyping software30 and phased haplotype data
from the Thousand Genomes Project (2010–2011 data freeze) that
included 1092 samples of mixed ethnicity who had had singleton
and monomorphic sites removed.
Covariates
A range of covariates pertaining to the study child, parents and
socioeconomic level were identified from the literature as potential
confounders of the relationship between age at menarche and
depressive symptoms/diagnosis.7,8,11,27,31–36 We included measures
of body mass index (BMI) from 9 and 15 years, proxies for pre-
and post-menarche BMI, since they are potentially associated with
age at menarche through different mechanisms.32–34 BMI was
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Fig. 1 Addressing the causal directions of effect in the
association between age at menarche and depressive
symptoms/depression, with the use of allelic risk scores
and Mendelian randomisation analysis.
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derived from height and weight measurements taken during
research clinics at 9 and 15 years. Where these were missing,
BMI was obtained from height and weight reported in question-
naires administered at 9 and 15 years (correlation coefficient
0.846).11 The number of older siblings was obtained from an
antenatal questionnaire and categorised into (a) none, (b) one,
or (c) two or more.
Maternal education was reported during the antenatal period
and defined as (a) certificate of secondary education or vocational
qualifications, (b) O-level qualifications, or (c) A-level and higher
qualifications. Maternal age at birth of the study child was derived
from questionnaires administered to the mother. Antenatal and
postnatal depression were derived from maternal questionnaires;
women self-reported antenatal depression at 18 and 32 weeks’
gestation, and also completed a series of questions between 8
weeks’ and 61 months’ post-birth, from which an Edinburgh
Postnatal Depression Score (EPDS)37 was calculated. The EPDS
was dichotomised at a cut-off of 12/13, the standard cut-off used
to indicate probable depressive disorder.38 We derived father
absence from a series of questionnaires completed by the mother.
Since there is evidence that family breakdown in the first 5 years
may have a greater influence on subsequent timing of
menarche,31,35 the variable was categorised to (a) father not absent
(b) father absent before child was age 5, or (c) father absent when
child was between 5 and 10 years.
Mother’s and partner’s occupations were reported in the
antenatal period and social class was derived using the 1991 Office
of Population Censuses and Surveys (OPCS) job codes: (a)
professional occupations; (b) managerial and technical occupations;
(c) skilled occupations (non-manual); (d) skilled occupations
(manual); (e) partly-skilled occupations; or (f) unskilled
occupations. Financial problems were reported by the mother in
a number of questionnaires between 8 weeks and 61 months
and we derived a variable that reflected any experience of financial
problems, and the effect on the family as perceived by the
mother.35 This was categorised as: (a) no financial problems; (b)
any reporting of financial problems, with a small effect; or (c)
any reporting of financial problems, with a large effect. Home
ownership was reported in questionnaires completed between 8
weeks’ gestation and 122 months’ post-birth. We included the first
reported answer, and the variable was dichotomised as living in
(a) owned or mortgaged property, or (b) rented property.
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Fig. 2 Flow chart showing sample sizes included in observational and Mendelian randomisation analyses.
a, Sample sizes for unadjusted observational analyses; b, sample sizes for adjusted observational analyses; c, sample sizes for Mendelian randomisation analyses.
SMFQ, Short Moods and Feelings Questionnaire; CIS-R, Clinical Interview Schedule-Revised.
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Statistical analysis
All analyses were carried out in Stata 13 MP2.
Descriptive and observational analyses
For continuous variables we calculated means and standard
deviations and explored the distribution of each variable. We
carried out regression analyses between the risk score and
potential confounders of the exposure–outcome relationship in
order to determine whether they were associated, which would
violate assumption 2 of Mendelian randomisation.
We carried out unadjusted logistic regression between
reported age at menarche and depressive symptoms/depression
using the ‘logistic’ command. We then adjusted the analyses for
the covariates described above.
Deriving the genetic score
A recent genome-wide association study (GWAS) meta-analysis
carried out across 57 studies with a total of up to 182 416 women
of European descent found 123 signals that are associated with age
at menarche.39 We extracted these variants from the genetic data
available in ALSPAC and tested for deviation from Hardy–
Weinberg equilibrium using the Stata command ‘hwsnp’. We
excluded two variants (rs17233066 and rs929843) from the score
on the basis of low imputation R2 values (R2 = 0.36 and 0.02,
respectively) and a third (rs16896742) that was neither genotyped
nor imputed in the ALSPAC cohort.
We summed the genetic dosages of the remaining 120 variants
to create a non-weighted genetic risk score for age at menarche.
Genetic dosages range from 0 to 2 at each site and represent the
expected number of age-at-menarche-reducing alleles for each
individual. We also created a categorical score by dividing the risk
score into quartiles, allowing the dose–response relationship to be
explored in analyses. We regressed the genetic risk score against
age at menarche in order to assess direct associations of the allele
score and phenotype (online Table DS1).
Mendelian randomisation analyses of genetic score and depressive
symptoms/depression
We carried out logistic regression analyses between the risk scores
and depressive symptoms/depression using the ‘xi:logistic’
command in Stata. Ten principal components were included to
control for confounding by population stratification.40 We then
carried out instrumental variable analyses of age at menarche
and depressive symptoms/depression with the ‘ivreg2’ command,
using the continuous risk score as an instrumental variable. We
used a structural mean model,41 allowing for binary outcomes
by using the ‘robust’ option, and again adjusted for all ten
principal components. F-statistics from the first-stage regression
between genetic risk scores and age at menarche were examined
to ensure that the instrument is strongly associated with the
exposure (using F410 as an arbitrary threshold), reducing the
risk of weak instrument bias.16 The ‘ivreg2’ command estimates
a causal risk difference in the outcome (depressive symptoms/
depression) per unit change in the exposure (age at menarche).
Sensitivity analyses
ALSPAC was included in the discovery GWAS meta-analysis,39
violating the assumption of independence between discovery
and study samples that is required for polygenic risk score
analyses.42 In order to correct for this violation of sample
independence we carried out sensitivity analyses in which we
removed the contribution of ALSPAC from the effect sizes
reported in the GWAS. We recalculated the overall effect under
a fixed-effect model after removing the estimate from the ALSPAC
study, by subtracting the quantities contributed by this study
(effect estimate and weight) from the weighted mean. We then
created a new weighted score, in which the effects of ALSPAC were
removed, and repeated regression and instrumental variable
analyses at age 14 years using this new score. We were also aware
that the existence of pleiotropy – when a genetic variant has an
effect on outcome independent of its effect on the exposure –
would violate assumption 3 of Mendelian randomisation.17 We
were aware of potential pleiotropic effects of age at menarche
SNPs with BMI43,44 and thus carried out sensitivity analyses to
determine the effect of this.
Ideally we would do this by excluding only those SNPs
associated with pre-menarche BMI from the risk score. Excluding
SNPs associated with post-pubertal BMI would risk introducing
collider bias, since we would essentially stratify analyses by
BMI.45 In this case, post-pubertal BMI is the collider and the
other variables are age at menarche and the confounders of the
relationship between BMI and depression. If we exclude post-
pubertal BMI SNPs, then we risk inducing an association between
age at menarche and these confounders which, in turn, could lead
to a spurious association with depression.46
Unfortunately, no published research that we are aware of
has identified SNPs distinctly associated with ‘pre- and post-
menarche’ rather than ‘childhood’ BMI. We were, however, able
to carry out some sensitivity analyses by creating three new risk
scores that excluded SNPs that were found in: (a) a GWAS of
BMI in adulthood;47 (b) a GWAS of BMI in childhood;48 and
(c) either the childhood or adulthood GWAS. We re-ran
Mendelian randomisation analyses with these three scores,
adjusted for ten principal components as before.
Furthermore, we used Bowden’s Mendelian randomisation–
Egger regression test49 in order to assess the potential violation
of assumption 3 of Mendelian randomisation (i.e. no direct effect
of the genetic variants on the outcome). This provides a valid test
of directional or unbalanced pleiotropy and a consistent estimate of
the true causal effect.49 The slope of the Mendelian randomisation–
Egger regression represents this true causal effect, and the intercept
provides evidence of pleiotropy if different from zero.
Results
Descriptive and observational analyses
The sample sizes used for analyses at each time point vary as a
result of availability of data but can be observed in Fig. 2.
The mean age at menarche was 12 years 8 months
(approximately 152 months), and this was similar across all
groups used in analyses (online Table DS2). The mean SMFQ
score and variability in the score increased with age (online Table
DS1). At 14 years, the proportion of girls with depressive
symptoms was highest among early maturers and lowest among
late maturers. By 19, the differences between the groups appear
to be negligible (online Table DS3).
All included SNPs were in Hardy–Weinberg equilibrium. The
genetic risk score had a normal distribution around a mean value
of 121.39 age-at-menarche-reducing alleles (online Fig. DS1) with
little change across the different samples (online Table DS4).
There was a strong negative association of the score with age at
menarche whereby a one-allele increase in the continuous risk
score was associated with a decrease in age at menarche of 0.42
months or approximately 11 days (95% CI 70.49 to 70.35,
P= 1.410728) (Table 1). Girls in the first, second, third and fourth
quartiles of the categorical risk score experienced menarche at
mean ages of 12 years and: 11 months; 9 months; 8 months;
and 6 months respectively.
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Depressive symptoms
Continuous age at menarche (months): after adjusting for
confounders we found strong evidence that a 1-month increase
in age at menarche was associated with 1% lower odds of
depressive symptoms at 14 years (95% CI 0.98–0.995, P= 0.003),
however, this association attenuated at 17 (95% CI 0.99–1.003,
P= 0.20) and 19 (95% CI 0.99–1.01, P=0.85) years (online Table
DS5).
Categorical age at menarche (early/normative/late onset):
adjusted analyses suggest a protective effect of late menarche on
depressive symptoms at both 14 and 17 years, whereby girls
who experienced menarche late had respectively 32% (95% CI
0.50–0.92, P=0.01) and 28% (95% CI 0.54–0.95, P= 0.02) lower
odds of depressive symptoms compared with normative onset
menarche (online Table DS5).
Depression
There was insufficient evidence to suggest that age at menarche
was associated with diagnosed depression at 18 years in adjusted
analyses when using either the categorical (95% CI 0.46–1.07,
P= 0.10) or the continuous (95% CI 0.98–1.004, P= 0.16) risk
scores (online Table DS5).
Analyses using the genetic risk scores
Mendelian randomisation analyses
There was strong evidence for an association between both the
continuous and categorical risk scores and higher levels of
depressive symptoms at 14 years. On average a one-allele increase
in the risk score was associated with a 2% increase in the odds of
depressive symptoms at 14 years (95% CI 1.005–1.04, P=0.01)
(Table 2). Girls in the fourth quartile of the risk score experienced
menarche on average 5 months earlier than girls in the first
quartile and had 74% higher odds of depressive symptoms at
14 years (95 CI 1.26–2.40, P= 0.001).
There was insufficient evidence to suggest that the association
between the categorical or continuous risk scores and depressive
symptoms persisted at 17 or 19 years, nor was there evidence of
an association with diagnosed depression at 18 years (Table 2).
Instrumental variable analyses
A first-stage F-statistic of 114.9 (P50.0001) indicates a very strong
instrument that explains 4.93% of variability in age at menarche,
confirming that assumption 1 of Mendelian randomisation is
fulfilled. At 14 years we obtained a result of a causal risk difference
of 0.0062, meaning that there will be an additional 6 girls per 1000
(or 62 per 10 000) with depressive symptoms, for each month of
earlier menarche.
Sensitivity analyses
In total 13 of the 123 SNPs in the discovery GWAS failed to reach
genome-wide significance (51078) without the contribution of
ALSPAC, although 12 of these showed suggestive associations with
age at menarche (P551075). Alongside the 3 SNPs previously
excluded from the score, this left us with a weighted score
composed of 107 SNPs. Results with this score were consistent
with those obtained with the original unweighted score and with
the weighted score that included the effects of ALSPAC (Table 3).
Of the 123 SNPs associated with age at menarche, five were
robustly associated with adult BMI (rs543874, rs3101336,
rs10938397, rs7138803 and rs12446632), and one with childhood
BMI (rs8050136). After excluding these SNPs from the respective
scores and re-running analyses, findings were consistent with
analyses undertaken using the complete risk score (online Table DS6).
The Mendelian randomisation–Egger test results show no
evidence of directional or unbalanced pleiotropy, with an intercept
value of 70.01 (95% CI 70.04 to 0.02, P=0.65), and a pooled
estimate of the causal effect of a month decrease in age at
menarche on depressive symptoms at 14 years of an OR= 1.03
(95% CI 70.98 to 1.08, P=0.27).
Discussion
Main findings
We found strong evidence for a causal effect of age at menarche on
depressive symptoms in mid-adolescence (14 years). This effect
did not persist into late adolescence (17–19 years), nor was there
evidence for a causal effect of age at menarche on depression at 18
years. To the best of our knowledge this is the first time that
Mendelian randomisation techniques have been used to examine
whether the widely reported association between age at menarche
and depressive symptoms/depression is causal. These techniques
allow us to confirm that the association observed is not solely as
a result of confounding.
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Table 1 Results of linear regression analyses of the continuous genetic risk score against the continuous age at menarche variable
and confounders
Genetic risk score
Variable n Estimate (95% CI) P
Age at menarche (months) 2772 70.42 (70.49 to 70.35) 1.410728
Body mass index at age 9 2705 0.04 (0.02 to 0.05) 2.01075
Body mass index at age 15 2122 0.05 (0.03 to 0.07) 2.01075
Maternal antenatal depression 2590 0.01 (70.01 to 0.02) 0.34
Maternal postnatal depression 2684 70.002 (70.02 to 0.01) 0.80
Maternal age 2709 70.02 (70.06 to 0.02) 0.30
Maternal education 2745 70.001 (70.01 to 0.00) 0.81
Social class 2645 1.010714 (70.01 to 0.01) 0.98
Financial problems 2704 70.003 (70.01 to 0.00) 0.20
Home ownership 2922 70.004 (70.02 to 0.01) 0.56
Father absence 2747 0.002 (0.00 to 0.01) 0.15
Siblings, n 2741 1.010714 (0.00 to 0.00) 0.85
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Strengths and limitations
The major strengths of this study are the longitudinal multiwave
design of ALSPAC, repeated measures of depressive symptoms
and depression from mid- to late-adolescence, and the availability
of genetic data. Since ALSPAC was included in the GWAS that
identified the genetic variants used in this analysis, our original
results might overestimate the effects of the genetic variants in
relation to age of menarche (overfitting). However, we attempted
to reduce this likelihood by: (a) using an unweighted score and
therefore not taking the potentially biased effect estimates into
account in analyses; and (b) repeating analyses with a weighted
score that excluded the effects of ALSPAC from the original
GWAS. This process of ‘de-meta-analysis’ does, however,
introduce error into the new effect estimates and therefore our
weighted score – although unbiased by the exclusion of ALSPAC
– is itself an imperfect instrument.
Testing for the potential pleiotropic effects of the score on the
estimates of the effect of age at menarche on depressive symptoms
using Mendelian randomisation–Egger shows no evidence of
pleiotropy and a similarly inverse association as that obtained
with instrumental variable regression. However, Mendelian
randomisation–Egger is quite a conservative test and provides a
causal estimate with large standard errors.
A further potential limitation of our study is that it may be
underpowered to detect a causal effect at older ages, since the
sample size for the adjusted analyses was reduced by
approximately a third between 14 and 19 years (Fig. 2) due to
sample attrition. However, previous analyses in ALSPAC used
continuous depressive symptom latent traits across samples with
varying degrees of missing data, and drew robust conclusions
across samples with complete and partial depressive symptoms.11
Furthermore, the consistent mean SNP score and standard
deviation (online Table DS4) suggest that the study populations
were genetically similar.
Potential explanations for our findings
This study provides increased understanding of the link between
menarche and depressive symptoms/depression. With regard to
our specific research questions: first, we find evidence for a causal
association between early menarche and increased levels of
depressive symptoms in mid-adolescence. Second, we do not find
evidence that the adverse effect of early menarche on depressive
symptoms persists into late adolescence. Hormonal, neuro-
cognitive and psychosocial factors could explain why girls with
early menarche experience increased levels of depressive
symptoms in mid-adolescence. Puberty is associated with an
overall increase in hormone levels, and also with dramatic
fluctuations in the levels of oestrogen circulating in the body.1
The body’s systems must rapidly adapt to higher and fluctuating
levels of hormones that may influence mood. For instance, the
hypothalamic–pituitary–adrenal (HPA) axis has to mature rapidly
and become sensitised to new hormonal feedback mechanisms.1
Dysregulation of the HPA axis has been linked to a susceptibility
to depression in women,50 and therefore onset of menarche
may increase depressive symptoms through this mechanism.
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Table 2 Mendelian randomisation analyses: odds ratios for
depressive symptoms at ages 14, 17 and 19 years
(SMFQ511), and for depression diagnosis consistent with
ICD-10 criteria at age 18, by continuous and categorical
risk scores
OR (95% CI) P
Continuous risk score
SMFQ at 14 (n=2404) 1.02 (1.005–1.04) 0.01
SMFQ at 17 (n=2145) 1.002 (0.99–1.02) 0.78
SMFQ at 19 (n=1570) 1.001 (0.98–1.02) 0.88
CISR at 18 (n=1910) 1.004 (0.98–1.03) 0.73
Categorical risk score
Depressive symptoms (SMFQ) at 14 (n=2404)
2nd Quartile 1.62 (1.18–2.25) 0.003
3rd Quartile 1.38 (0.99–1.92) 0.05
4th Quartile 1.74 (1.26–2.40) 0.001
Trend 1.15 (1.04–1.27) 0.005
Depressive symptoms (SMFQ) at 17 (n=2145)
2nd Quartile 0.95 (0.71–1.26) 0.73
3rd Quartile 0.90 (0.68–1.21) 0.49
4th Quartile 1.08 (0.82–1.43) 0.59
Trend 1.02 (0.93–1.12) 0.68
Depressive symptoms (SMFQ) at 19 (n=1570)
2nd Quartile 0.74 (0.52–1.04) 0.08
3rd Quartile 0.81 (0.58–1.12) 0.20
4th Quartile 1.06 (0.76–1.46) 0.74
Trend 1.02 (0.92–1.14) 0.70
Depression (CIS-R) at 18 (n=1910)
2nd Quartile 0.84 (0.55–1.28) 0.41
3rd Quartile 0.83 (0.54–1.26) 0.37
4th Quartile 1.14 (0.76–1.70) 0.53
Trend 1.04 (0.91–1.19) 0.57
SMFQ, Short Moods and Feelings Questionnaire; CIS-R, Clinical Interview Schedule-
Revised.
Table 3 Sensitivity analyses: coefficients for depressive symptoms at age 14 years (SMFQ511) by unweighted, weighted (including
ALSPAC) and weighted (excluding ALSPAC) genetic risk scores
Coefficient (95% CI) OR (95% CI)a P
Unweighted score
Association of score with depressive symptoms at 14 1.02 (1.005 to 1.04) 0.01
Association of score with age at menarche 70.42 (70.49 to 70.35)b 50.001
Instrumental variable analysis 0.006 (0.001 to 0.01)c 0.02
Weighted score (including ALSPAC)
Association of score with depressive symptoms at 14 1.04 (1.01 to 1.07) 0.02
Association of score with age at menarche 70.86 (71.00 to 70.72)b 50.001
Instrumental variable analysis 0.006 (0.001 to 0.01)c 0.03
Weighted score (excluding ALSPAC)
Association of score with depressive symptoms at 14 1.03 (0.998 to 1.07) 0.06
Association of score with age at menarche 70.74 (70.89 to 70.59)b 50.001
Instrumental variable analysis 0.006 (70.001 to 0.01)c 0.07
SMFQ, Short Moods and Feelings Questionnaire; ALSPAC, Avon Longitudinal Study of Parents and Children.
a. OR per unit increase in score.
b. Change in age at menarche in months per unit increase in score.
c. Risk difference per month decrease in age at menarche.
Association of timing of menarche with depression
Furthermore, these hormonal and neurocognitive changes occur
around the time that girls are exposed to a range of new biological
and psychosocial stressors,6 making them particularly vulnerable
to dysregulation during this sensitive transition period.
The psychosocial ‘off-time’ and ‘early-timing’ hypotheses51
have been explored in studies examining the link between age at
menarche and depressive symptoms/depression.8,10,15 They
suggest that girls who experience menarche out of sync with
(‘off-time’) or significantly before (‘early-timing’) their peers
are more likely to develop depressive symptoms/depression.
Inconsistency between levels of biological and cognitive
maturation, as well as feelings of being ‘different’ to one’s peers,
may induce psychological distress and depressive symptoms.6
The early-timing hypothesis further explains the higher levels of
depression and depressive symptoms in early-maturing girls by
suggesting that they are particularly ill-equipped to deal with
the psychosocial consequences of puberty because of their relative
cognitive immaturity at the time of menarche.51
Our findings suggest that the mood-related changes linked to
onset of menarche are transient since in late adolescence (i.e. when
all girls have experienced the menarcheal transition) there were no
differences in the level of depressive symptoms according to
timing of menarche. This is consistent with previous findings
from a number of prospective studies, including an earlier study
with the ALSPAC cohort,11 suggesting that the associations
between timing of menarche and depressive symptoms/depression
dissipate in late adolescence.9,13,14,52
Higher levels of depressive symptoms/depression observed in
mid-adolescence could be due to the fact that girls with earlier
menarche are experiencing this rise earlier than their peers. The
apparent differences in depressive symptoms/depression in earlier-
v. later-maturing girls may then dissipate as a result of two
concurrent processes: ‘catch-up’ by girls with later-onset menarche
as they experience the rise in level of depressive symptoms
associated with the menarcheal transition, and ‘recovery’ (i.e.
reduced levels of depressive symptoms) in girls who experienced
early menarche.13
There are suggestions of catch-up by later maturers in our
study (online Table DS3), and recovery had been explored
previously. A prospective study that mapped the trajectories of
depression before and after puberty found that rates of depression
in girls followed an inverse U-shaped curve over age, falling
steadily after reaching a peak in late adolescence (16–17 years)
and continuing to fall until at least 23 years.52 This raises the
question of whether the girls with late-onset menarche in our
study might still have high transitional levels of depressive
symptoms in late adolescence, and might eventually recover to a
lower level of depressive symptoms than girls who experienced
earlier menarche. Further collection of data on depressive
symptoms in the ALSPAC cohort will enable investigation of this
research question.
Studies examining depression risk by age at menarche in the
longer term have had mixed outcomes, with some indicating
higher adult levels of depression among women who had late
menarche,12 and others among those with early menarche.53
Further studies are needed that include measures of depression
outcomes throughout adulthood to examine whether there are
long-term adverse effects of early-onset menarche.
Implications and extensions of this research
Our findings have important implications for understanding the
aetiology of depression and depressive symptoms. We have found
evidence for a causal effect of early-onset menarche on depressive
symptoms in mid-adolescence, supporting results found in
observational studies. For healthcare practitioners, there should
be awareness that onset of menarche is associated with a rise in
depressive symptoms, and that girls who experience early
menarche will experience this rise in depressive symptoms at an
earlier age.
Together with the replication of our findings in other cohorts,
we suggest that further Mendelian randomisation studies may
help to uncover the mechanisms and pathways through which
menarche influences the risk of depressive symptoms/depression.
Such studies may highlight potentially modifiable targets for
intervention.11 The consistent results obtained from sensitivity
analyses suggest that the effects of menarche on depressive
symptoms/depression do not act solely through menarche-related
changes in BMI. The publication of a GWAS that robustly
identifies the SNPs associated with pre- and post-pubertal BMI
would enable clarification of the pathways linking menarche,
depressive symptoms/depression and BMI.
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Table DS1 Means and Standard Deviations of Continuous Variables  
Variable Number Mean Std. Dev. Min. Max. 
Age at menarche (months) 4282 151.52 14.11 91 203 
Genetic risk score 4075 121.39 6.74 99.87 143.09 
Genetic risk score without adult 
BMI SNPs1 4075 116.45 6.60 95.01 138.09 
Genetic risk score without 
childhood BMI SNPs1 4075 120.59 6.69 98.88 142.09 
Genetic risk score without adult 
or childhood BMI SNPs1 4075 115.66 6.55 94.01 137.82 
SMFQ2 result at 14 3076 5.71 4.93 0 26 
SMFQ2 result at 16 2969 7.00 6.02 0 26 
SMFQ2 result at 18 2152 7.63 6.21 0 26 
BMI at 9 4236 17.93 3.10 11.47 45.89 
BMI at 15 2846 21.82 3.70 14.09 42.00 
1Genetic risk score created for sensitivity analyses; 2Short Moods and Feelings Questionnaire 
 
Table DS2 The Mean Age at Menarche of Girls with Short Moods and Feelings Questionnaire (SMFQ) 
and Clinical Interview Schedule – Revised (CIS-R) Measures in Middle to Late Adolescence.  
Population 
No. 
Observations 
Mean age at 
menarche 
(months) 
Standard 
deviation Minimum Maximum 
All girls with age at 
menarche data 3982 151.86 14.02 91.00 203.00 
SMFQ at 14 years 2804 152.87 13.80 91.00 200.00 
SMFQ at 17 years 2659 152.52 14.19 91.00 203.00 
SMFQ at 19 years 1902 152.58 13.92 91.00 200.00 
CIS-R at 18 years 2208 152.54 13.80 91.00 200.00 
 
  
 Table DS3: Number and Proportion of Girls with Depressive Symptoms (Short Moods and Feelings 
Questionnaire (SMFQ)>=11) and Depression (Clinical Interview Schedule – Revised (CIS-R)) by Age at 
Menarche (Early/Normative/Late) 
Age at menarche SMFQ>=11 at 14 
SMFQ>=11 
at 17 
SMFQ>=11 
at 19 
CIS-R indicates 
depression at 18 
Early 
Number 439 439 301 354 
% with depressive 
symptoms (SMFQ) or 
depression (CIS-R) 19.82 23.92 22.92 12.43 
Normative 
Number 1611 1523 1099 1274 
% with depressive 
symptoms (SMFQ) or 
depression (CIS-R) 16.08 23.44 22.66 10.68 
Late 
Number 754 697 502 580 
% with depressive 
symptoms (SMFQ) or 
depression (CIS-R) 11.94 20.23 20.92 7.93 
Total 
Number 2804 2659 1902 2208 
% with depressive 
symptoms (SMFQ) or 
depression (CIS-R) 15.55 22.68 22.24 10.24 
 
 
 
 
 
 
 Fig. DS1 Distribution of the Continuous Genetic Risk Score 
 
 
 
Table DS4: The Mean Genetic Risk Score of Girls with Short Moods and Feelings 
Questionnaire (SMFQ) and Clinical Interview Schedule – Revised (CIS-R) Measures in Middle 
to Late Adolescence. 
Population 
No. 
Observations 
Mean 
genetic 
risk score 
Standard 
deviation Minimum Maximum 
All girls with genetic 
data 4075 121.39 6.74 99.87 143.09 
SMFQ at 14 years 2404 121.28 6.87 99.87 143.09 
SMFQ at 17 years 2145 121.35 6.84 99.87 143.09 
SMFQ at 19 years 1570 121.31 6.83 99.87 143.09 
CIS-R at 18 years 1910 121.40 6.88 99.87 143.09 
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Table DS5: Observational Analyses: Adjusted Odds Ratios (and 95% Confidence Intervals) for 
Depressive Symptoms at Ages 14, 17 and 19 Years (SMFQ>=11), and for Depression 
Diagnosis Consistent with ICD-10 Criteria at Age 18. Results Shown for Models with 
Continuous and Categorical Age at Menarche Variables 
 
Depressive 
symptoms 
(SMFQ>=11) at 14 
(n=2,113) 
Depressive 
symptoms 
(SMFQ>=11) at 17 
(n=1,913) 
Depressive 
symptoms 
(SMFQ>=11) at 19 
(n=1,408) 
Depression (CIS-R) 
at 18 (n=1,648) 
Continuous age at menarche 
Per 1-month 
later 
menarche 
0.99 (0.98, 0.995) 
p=0.003 
0.99 (0.99, 1.003) 
p=0.20 
0.999 (0.99, 1.01) 
p=0.85 
0.99 (0.98, 1.004) 
p=0.16 
Categorical age at menarche 
Normative 1.00 1.00 1.00 1.00 
Early 1.17 (0.84, 1.62) p=0.36 
0.83 (0.61, 1.15) 
p=0.27 
0.88 (0.61, 1.28) 
p=0.51 
1.02 (0.65, 1.60) 
p=0.93 
Late 0.68 (0.50, 0.92) p=0.01 
0.72 (0.54, 0.95) 
p=0.02 
0.89 (0.64, 1.23) 
p=0.49 
0.71 (0.46, 1.07) 
p=0.10 
p-value for 
linear trend 0.02 0.06 0.69 0.24 
All analyses adjusted for: BMI at 9 years; BMI at 15 years; No. older siblings; Maternal education; 
Maternal age; Maternal AN depression; Maternal PN depression; Father absence; Social class; Financial 
problems; Home ownership. 
 
 
 
 
 
 
 
 
 
  
Table DS6: Sensitivity Analyses: Odds ratios and 95% Confidence Intervals for Depressive 
Symptoms at Ages 14, 17 and 19 Years (SMFQ>=11), and for Depression Diagnosis 
Consistent with ICD-10 Criteria at Age 18, by Continuous and Categorical Risk Scores. 
  
(1) Risk score with adult BMI 
variants removed 
(score includes 115 variants) 
(2) Risk score with childhood 
BMI variants removed 
(score includes 119 variants) 
(3) Risk score with adult and 
childhood BMI SNPs removed 
(score includes 114 variants) 
Continuous risk score 
  OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value 
MFQ at 141 1.02 (1.01, 1.04) 0.005 1.02 (1.00, 1.04) 0.01 1.02 (1.01, 1.04) 0.006 
MFQ at 172 1.00 (0.99, 1.02) 0.61 1.00 (0.99, 1.01) 0.84 1.00 (0.99, 1.02) 0.84 
MFQ at 193 1.00 (0.99, 1.02) 0.63 1.00 (0.98, 1.02) 0.96 1.00 (0.99, 1.02) 0.96 
CISR at 184 1.01 (0.99, 1.03) 0.45 1.00 (0.98, 1.02) 0.84 1.01 (0.99, 1.03) 0.84 
Categorical risk score 
Depressive symptoms (SMFQ) at 14 (n=2,404) 
2nd Quartile 1.47 (1.06, 2.05) 0.02 1.59 (1.15, 2.19) 0.005 1.36 (0.98, 1.88) 0.005 
3rd Quartile 1.46 (1.06, 2.02) 0.02 1.47 (1.06, 2.04) 0.02 1.43 (1.04, 1.98) 0.029 
4th Quartile 1.67 (1.21, 2.30) 0.002 1.58 (1.13, 2.19) 0.006 1.59 (1.15, 2.18) 0.005 
Trend 1.16 (1.05, 1.28) 0.004 1.13 (1.02, 1.25) 0.02 1.15 (1.04, 1.27) 0.006 
Depressive symptoms (SMFQ) at 17 (n=2,145) 
2nd Quartile 1.00 (0.75, 1.34) 1.00 0.96 (0.72, 1.28) 0.8 0.98 (0.74, 1.31) 0.90 
3rd Quartile 1.02 (0.77, 1.35) 0.91 0.93 (0.70, 1.25) 0.65 0.90 (0.68, 1.20) 0.49 
4th Quartile 1.09 (0.82, 1.45) 0.54 1.03 (0.78, 1.37) 0.82 1.07 (0.81, 1.42) 0.64 
Trend 1.03 (0.94, 1.13) 0.54 1.01 (0.92, 1.10) 0.88 1.01 (0.93, 1.11) 0.79 
Depressive symptoms (SMFQ) at 19 (n=1,570) 
2nd Quartile 0.93 (0.66, 1.31) 0.67 0.73 (0.52, 1.03) 0.07 0.79 (0.56, 1.11) 0.17 
3rd Quartile 0.96 (0.69, 1.34) 0.81 0.83 (0.60, 1.15) 0.26 0.93 (0.67, 1.29) 0.66 
4th Quartile 1.06 (0.76, 1.49) 0.73 0.96 (0.69, 1.33) 0.80 1.00 (0.72, 1.40) 0.99 
Trend 1.02 (0.92, 1.14) 0.72 1.00 (0.89, 1.11) 0.93 1.02 (0.91, 1.13) 0.79 
Depression (CIS-R) at 18 (n=1,910) 
2nd Quartile 0.73 (0.47, 1.13) 0.16 1.10 (0.72, 1.66) 0.67 0.88 (0.57, 1.34) 0.54 
3rd Quartile 0.88 (0.58, 1.34) 0.55 0.95 (0.62, 1.44) 0.79 0.83 (0.55, 1.27) 0.39 
4th Quartile 1.20 (0.81, 1.79) 0.36 1.09 (0.72, 1.66) 0.69 1.19 (0.80, 1.77) 0.40 
Trend 1.08 (0.95, 1.23) 0.26 1.01 (0.89, 1.14) 0.88 1.05 (0.92, 1.20) 0.47 
 1n=2,404; 2n=2,145; 3n=1,570; 4n=1,910 
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